Fatty infiltration of the pancreas: a systematic concept analysis
MA Mahyoub, M Elhoumed, AH Maqul… - Frontiers in …, 2023 - frontiersin.org
Fatty infiltration of the pancreas (FIP) has been recognized for nearly a century, yet many
aspects of this condition remain unclear. Regular literature reviews on the diagnosis …
aspects of this condition remain unclear. Regular literature reviews on the diagnosis …
Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?
Metabolic syndrome (MetS) is a cluster of central obesity, dyslipidaemia, insulin resistance
and hypertension. MetS frequently co-exists with non-alcoholic fatty liver disease (NAFLD) …
and hypertension. MetS frequently co-exists with non-alcoholic fatty liver disease (NAFLD) …
Diabetes mellitus and obesity as risk factors for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The
worldwide estimates of its incidence and mortality in the general population are eight cases …
worldwide estimates of its incidence and mortality in the general population are eight cases …
Nonalcoholic fatty pancreas disease: role in metabolic syndrome,“prediabetes,” diabetes and atherosclerosis
TD Filippatos, K Alexakis, V Mavrikaki… - Digestive Diseases and …, 2022 - Springer
Fat accumulation in the pancreas associated with obesity and the metabolic syndrome
(MetS) has been defined as “non-alcoholic fatty pancreas disease”(NAFPD). The aim of this …
(MetS) has been defined as “non-alcoholic fatty pancreas disease”(NAFPD). The aim of this …
The coexistence of nonalcoholic fatty liver disease and type 2 diabetes mellitus
M Kosmalski, S Ziółkowska, P Czarny… - Journal of Clinical …, 2022 - mdpi.com
The incidence of nonalcoholic fatty liver disease (NAFLD) is growing worldwide.
Epidemiological data suggest a strong relationship between NAFLD and T2DM. This is …
Epidemiological data suggest a strong relationship between NAFLD and T2DM. This is …
Non-alcoholic fatty liver in patients with chylomicronemia
M Maltais, D Brisson, D Gaudet - Journal of clinical medicine, 2021 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is frequent in patients with features of the
metabolic syndrome (MetS), obesity, or type 2 diabetes. Lipoprotein lipase (LPL) is the main …
metabolic syndrome (MetS), obesity, or type 2 diabetes. Lipoprotein lipase (LPL) is the main …
Non‐alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single …
Background and Aim Non‐alcoholic fatty pancreas disease (NAFPD) is a disease that
ranges from simple steatosis and can further lead to chronic pancreatitis and possible …
ranges from simple steatosis and can further lead to chronic pancreatitis and possible …
Impact of fatty pancreas on postoperative pancreatic fistulae: a meta-analysis
L Zhou, W **ao, C Li, Y Gao, W Gong, G Lu - Frontiers in Oncology, 2021 - frontiersin.org
Background Soft pancreas is widely recognized as an important risk factor for the
development of postoperative pancreatic fistula (POPF). Although fatty pancreas (FP) has …
development of postoperative pancreatic fistula (POPF). Although fatty pancreas (FP) has …
Non-alcoholic fatty pancreas disease–practices for clinicians
Obesity is a growing health burden worldwide, increasing the risk for several diseases
featuring the metabolic syndrome–type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty …
featuring the metabolic syndrome–type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty …
Hypothalamic dysfunction in obesity and metabolic disorders
The hypothalamus is the brain region responsible for the maintenance of energetic
homeostasis. The regulation of this process arises from the ability of the hypothalamus to …
homeostasis. The regulation of this process arises from the ability of the hypothalamus to …